Recently, Mei Shi Yeo et al. reported that FBXW5 may promote GC tumorigenesis and metastasis by activating the FAK-Src signaling pathway, which indicated that FBXW5 might be a potential therapeutic target [23]. Here, SRC is linked to gastric cancer.